The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
That’s it and that’s all.
Final curtain.
"Writing on LinkedIn, Mr Moulding said: "Just about every major PE firm has enquired about taking THG private. Usually, nobody finds out. But if there’s a leak, then the Takeover Panel forces an announcement. This is what happened with Apollo.
"PE interest isn’t surprising. For the three years before IPO, THG shares traded at £3. Having doubled in size we then listed THG at £5 a share in Sep 20. They rose to £8 in the first-year post IPO but, after the Numis led short attacks when they weren’t made a broker to THG, shares fell to as low as 30p in late 2022.
"The last time THG shares traded at 30p was in 2009, when the group had £80m sales and only sold CDs! Today THG is 28 x bigger."
Tom Adams, experience consulting and marketing transformation leader for PwC UK, added: "As -ecommerce becomes an increasingly critical channel for client growth, we look forward to combining our deep industry, strategic and creative expertise with Ingenuity's powerful ecommerce technology and operations to help brands reduce costs, grow revenues and improve customer engagement, satisfaction and loyalty."
You speak for yourself Rock. Don’t keep making wild statements as if all private investors agree with your agenda.
I certainly don’t.
And I don’t think Matt is mad in the slightest. He’s built and is running a multimillion pound company. What are you doing apart from bit*hing on a two bit bulletin board on a Saturday?
There is no ‘we’.